Specify a stock or a cryptocurrency in the search bar to get a summary
Chengdu Easton Biopharmaceuticals Co Ltd
688513Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry, and urinary system therapeutic categories. The company was founded in 2009 and is based in Chengdu, China. Address: No. 8, Ankang Road, Chengdu, China, 610200
Analytics
WallStreet Target Price
303.19 CNYP/E ratio
25.3077Dividend Yield
1.69 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 688513
Dividend Analytics 688513
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
19 %Dividend History 688513
Stock Valuation 688513
Financials 688513
Results | 2019 | Dynamics |